http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016034929-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95585944cd76ddfb6dc33ed2a0b84403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e14569f4c14ce2a060a6d97168109fa |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 |
filingDate | 2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1d31a5c210cfea8f94f766c564f9c8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d3722f2fbb4fd78bb418112a86e3e02 |
publicationDate | 2016-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2016034929-A |
titleOfInvention | Insulin secretion promoter, blood sugar level reducing agent, and diabetes preventive or therapeutic agent |
abstract | An object of the present invention is to provide an insulin secretion promoter, a GLP-1 secretion promoting action, a blood glucose level improving agent, a diabetes preventive agent or a diabetes therapeutic agent containing a pyrrolizidine compound or a salt thereof. An insulin secretagogue, a GLP-1 secretagogue, a blood glucose level, comprising a compound represented by the following formula (1-1), (1-2), or (1-3) or a salt thereof: An improving agent, a preventive agent for diabetes or a therapeutic agent for diabetes is provided. [Selection] Figure 1 |
priorityDate | 2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.